CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Hospital & Medical Service Plans
- Revenue
- $1.9B
- 40% YoY
- Operating margin
- -4.4%
- 33% YoY
- EBITDA
- −$84M
- 89% YoY
- Market cap
- $2.4B
- Employees
- 724
- $3M revenue each
- Net debt / EBITDA
- —
- −$73M net debt
- AI in 10-K
- 5.9
- mentions per 10K words
Takeover score 2 of 13
Fixable underperformance 1 of 7
- TSR below peersYes5 of 5 years3+ of last 5 years
- High CEO pay despite TSRNo$9M medianMedian CEO pay ≥ $15M while TSR trails
- Earnings not backed by cashNo—Cash flow under 80% of net income
- Dilutive SBCNo5% of revenueOver 10% of revenue
- Payouts exceed cash flowNo-27% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyNo0% of assetsOver 40% of assets
- Shareholder dissentNo85% lowest supportAny vote under 80% support
Buyer economics 1 of 4
- Low revenue per employeeNo$3M · 74th pctBottom quartile of its SIC industry
- Quiet on AINo5.9 per 10K words · 85th pctBottom quartile of AI mentions in 10-Ks
- Net cashNo—More cash than debt, positive EBITDA
- Buyout-sizedYes$2.4B market capMarket cap $500M–$5B
Catalysts 0 of 2
- Active 13DNo0 filingsActive-intent 13D in 18 months
- Net insider sellingNo−$9M netNet sales over $10M in 12 months
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $1.5B | $1.1B | $1.3B | $1.4B | $1.9B | 40% |
| Operating income | −$637M | −$287M | −$205M | −$46M | −$86M | 87% |
| Net income | −$588M | −$339M | −$213M | −$43M | −$86M | 99% |
| Operating cash flow | −$282M | −$204M | −$145M | $35M | −$67M | 292% |
| Capex | $723K | $4M | $584K | $2M | $2M | 31% |
| Stock-based comp | $164M | $164M | $141M | $114M | $104M | 9.3% |
| Buybacks | $147K | $0 | $0 | $2M | $18M | 933% |
Deal filings
| Filed | Form | Acquirer | Price | Premium |
|---|---|---|---|---|
| Dec 14, 2020 | DEFM14A | — | $0.00 | — |
13D filers
| Filed | Filer | Form | Stake | Intent |
|---|---|---|---|---|
| Oct 4, 2022 | ChaChaCha SPAC C, LLC | SC 13D/A | 5.0% | Passive |
| Jan 14, 2022 | SCH Sponsor III LLC | SC 13D/A | 8.6% | Passive |
| Jan 19, 2021 | Garipalli Vivek | SC 13D | 36.8% | Passive |
| Jan 15, 2021 | SCH Sponsor III LLC | SC 13D | 20.4% | Passive |
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $9M · 42
- Net
- −$9M
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2025 | $1M | −$3M | 15 | 96 |
| FY2024 | $9M | $24M | 20 | 78 |
| FY2023 | $10M | $11M | 6 | 79 |
| FY2022 | $0 | −$39M | 6 | 74 |
| FY2021 | $390M | $62M | 23 | 93 |